Feasibility and Diagnostic Validity of the M-3 Checklist: A Brief, Self-Rated Screen for Depressive, Bipolar, Anxiety, and Post-Traumatic Stress Disorders in Primary Care

被引:48
作者
Gaynes, Bradley N. [1 ]
DeVeaugh-Geiss, Joanne [1 ]
Weir, Sam [2 ]
Gu, Hongbin [1 ]
MacPherson, Cora [3 ]
Schulberg, Herbert C. [4 ]
Culpepper, Larry [5 ]
Rubinow, David R. [1 ]
机构
[1] Univ N Carolina, Sch Med, Dept Psychiat, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Sch Med, Dept Family Med, Chapel Hill, NC 27599 USA
[3] Social & Sci Syst Inc, Silver Spring, MD USA
[4] Cornell Univ, Dept Psychiat, Weill Med Coll, White Plains, NY USA
[5] Boston Univ, Sch Med, Dept Family Med, Boston, MA 02118 USA
基金
美国医疗保健研究与质量局;
关键词
Mental health; health promotion; disease prevention; mass screening; depression; anxiety disorder; bipolar disorder; stress disorders; post-traumatic; primary health care; NEUROPSYCHIATRIC INTERVIEW MINI; PATIENT HEALTH QUESTIONNAIRE-9; DSM-IV DISORDERS; MENTAL-HEALTH; SPECTRUM DISORDER; PREVALENCE; COMORBIDITY; MOOD; VALIDATION; RELIABILITY;
D O I
10.1370/afm.1092
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
PURPOSE Mood and anxiety disorders are the most common psychiatric conditions seen in primary care, yet they remain underdetected and undertreated. Screening tools can improve detection, but available instruments are limited by the number of disorders assessed. We wanted to assess the feasibility and diagnostic validity of the My Mood Monitor (M-3) checklist, a new, 1-page, patient-rated, 27-item tool developed to screen for multiple psychiatric disorders in primary care. METHODS We enrolled a sample of 647 consecutive participants aged 18 years and older who were seeking primary care at an academic family medicine clinic between July 2007 and February 2008. We used a 2-step scoring procedure to make screening more efficient. The main outcomes measured were the sensitivity and specificity of the M-3 for major depression, bipolar disorder, any anxiety disorder, and post-traumatic stress disorder (PTSD), a specific type of anxiety disorder. Using a split sample technique, analysis proceeded from determination of optimal screening thresholds to assessment of the psychometric properties of the self-report instrument using the determined thresholds. We used the Mini International Neuropsychiatric Interview as the diagnostic standard. Feasibility was assessed with patient and physician exit questionnaires. RESULTS The depression module had a sensitivity of 0.84 and a specificity of 0.80. The bipolar module had a sensitivity of 0.88, and a specificity of 0.70. The anxiety module had a sensitivity of 0.82 and a specificity of 0.78, and the PTSD module had a sensitivity of 0.88 and a specificity of 0.76. As a screen for any psychiatric disorder, sensitivity was 0.83 and specificity was 0.76. Patients took less than 5 minutes to complete the M-3 in the waiting room, and less than 1% reported not having time to complete it. Eighty-three percent of clinicians reviewed the checklist in 30 or fewer seconds, and 80% thought it was helpful in reviewing patients' emotional health. CONCLUSIONS The M-3 demonstrates utility as a valid, efficient, and feasible tool for screening multiple common psychiatric illnesses, including bipolar disorder and PTSD, in primary care. Its diagnostic accuracy equals that of currently used single-disorder screens and has the additional benefit of being combined into a 1-page tool. The M-3 potentially can reduce missed psychiatric diagnoses and facilitate proper treatment of identified cases.
引用
收藏
页码:160 / 169
页数:10
相关论文
共 62 条
[1]   Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: A randomized, parallel group, open-label trial [J].
Amsterdam, Jay D. ;
Wang, Chia-Hao ;
Shwarz, Michelle ;
Shults, Justine .
JOURNAL OF AFFECTIVE DISORDERS, 2009, 112 (1-3) :219-230
[2]  
[Anonymous], 1991, USERS GUIDE GEN HLTH
[3]  
[Anonymous], 2000, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890425787
[4]  
[Anonymous], HLTH US 2006 CHARTB
[5]   Screening for depression: Recommendations and rationale [J].
Berg, AO ;
Allan, JD ;
Frame, PS ;
Homer, CJ ;
Johnson, MS ;
Klein, JD ;
Lieu, TA ;
Mulrow, CD ;
Orleans, CT ;
Peipert, JF ;
Pender, NJ ;
Siu, AL ;
Teutsch, SM ;
Westhoff, C ;
Woolf, SH .
ANNALS OF INTERNAL MEDICINE, 2002, 136 (10) :760-764
[6]   Antidepressant-Associated Mood Elevations in Bipolar II Disorder Compared With Bipolar I Disorder and Major Depressive Disorder: A Systematic Review and Meta-Analysis [J].
Bond, David J. ;
Noronha, Melissa M. ;
Kauer-Sant'Anna, Marcia ;
Lam, Raymond W. ;
Yatham, Lakshmi N. .
JOURNAL OF CLINICAL PSYCHIATRY, 2008, 69 (10) :1589-1601
[7]   Mood and anxiety disorders in women with treated hyperthyroidism and ophthalmopathy caused by Graves' disease [J].
Bunevicius, R ;
Velickiene, D ;
Prange, AJ .
GENERAL HOSPITAL PSYCHIATRY, 2005, 27 (02) :133-139
[8]   Psychopathological sequelae of the 11 March terrorist attacks in Madrid [J].
Conejo-Galindo, Javier ;
Medina, Oscar ;
Fraguas, David ;
Teran, Sara ;
Sainz-Corton, Enrique ;
Arango, Celso .
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2007, 258 (01) :28-34
[9]   Screening for bipolar disorder in a primary care practice [J].
Das, AK ;
Olfson, M ;
Gameroff, MJ ;
Pilowsky, DJ ;
Blanco, C ;
Feder, A ;
Gross, R ;
Neria, Y ;
Lantigua, R ;
Shea, S ;
Weissman, MM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (08) :956-963
[10]  
Depression Guideline Panel, 1993, AHCPR PUBL, V2